Get started
Author

Elizabeth Hatcher Frush

Observed names: E. Frush, Elizabeth Frush, Elizabeth H. Frush
ORCID: 0000-0003-3611-132X
Observed ORCID: 0000-0003-3611-132X
OpenAlex ID: A5114457552
Real-World Applications and Experiences of AI/ML Deployment for Drug Discovery
2025 · Will R. Pitt, Jonathan Bentley, et al. · Journal of Medicinal Chemistry · 45
PDF
In Silico Prediction of Ligand Binding Energies in Multiple Therapeutic Targets and Diverse Ligand Sets—A Case Study on BACE1, TYK2, HSP90, and PERK Proteins
2017 · Elizabeth Hatcher Frush, Sivakumar Sekharan, et al. · The Journal of Physical Chemistry B · 14
Leveraging Cloud Computing for In-Silico Drug Design Using the Quantum Molecular Design (QMD) Framework
2018 · Shahar Keinan, Elizabeth Hatcher Frush, et al. · Computing in Science & Engineering · 13
Orthosteric inhibition of MutSβ ATPase function: First disclosure of MSH3-bound small molecule inhibitors
2025 · Gareth N. Brace, Karsten Tillack, et al. · Bioorganic & Medicinal Chemistry Letters · 6
PDF
Post-translational modifications of huntingtin's N17 region: implications for self-association and membrane binding
2025 · Mariana Gallo, Raffaele Ingenito, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 1
ChemEidos: Synthesis-Aware Multimodal Foundation Models for Domain-Specific Generative Design
2026 · Jacob M. Remington, Elizabeth H. Frush, et al. · ChemRxiv
PDF
Assessing the state of the art in ADMET prediction: Lessons from the OpenADMET-ExpansionRx community blind challenge
2026 · Maria A. Castellanos, Hugo MacDermott-Opeskin, et al. · ChemRxiv
PDF
Works count: 8
Citation count: 79
H-index: 4
I10-index: 3
Year
Topic
Type